BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1676714)

  • 1. Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists.
    Kohn A; Annibale B; Prantera C; Giglio L; Suriano G; Delle Fave G
    J Clin Gastroenterol; 1991 Jun; 13(3):284-90. PubMed ID: 1676714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients.
    Bianchi Porro G; Imbimbo BP; Lazzaroni M
    Agents Actions; 1988 Aug; 25(1-2):22-6. PubMed ID: 3055874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin in the control of gastric acid secretion and gastrin release in response to a meal at low and high pH in healthy subjects and duodenal ulcer patients.
    Konturek JW; Konturek SJ; Domschke W
    Scand J Gastroenterol; 1995 Aug; 30(8):738-44. PubMed ID: 7481540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.
    Brozinsky S; Hogan DL; Isenberg JI; Richardson CT
    Dig Dis Sci; 1984 Feb; 29(2):129-33. PubMed ID: 6141898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.
    Mohammed R; Holden RJ; Hearns JB; McKibben BM; Buchanan KD; Crean GP
    Gut; 1983 Jan; 24(1):61-6. PubMed ID: 6129180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duodenal ulcer patients.
    Gisbert JP; Boixeda D; Vila T; de Rafael L; Redondo C; de Argila CM
    J Clin Gastroenterol; 1996 Mar; 22(2):90-5. PubMed ID: 8742644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers.
    Konturek SJ; Swierczek JS; Kwiecien N; Obtułowicz W; Sito E; Oleksy J
    Scand J Gastroenterol; 1979; 14(7):813-9. PubMed ID: 395627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Much ado about gastrin.
    McQuaid KR
    J Clin Gastroenterol; 1991 Jun; 13(3):249-54. PubMed ID: 1676713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A global study of gastric secretion in duodenal ulcers: gastrin, pepsinogen and acid secretion].
    Gisbert JP; Boixeda D; Vila T; Martín de Argila C; Bermejo F; al-Mostafa A; de la Serna C
    Rev Esp Enferm Dig; 1995 Jul; 87(7):491-7. PubMed ID: 7662416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of histamine H2-antagonists on serum gastrin levels in gastric lumen-perfused rats].
    Yagita M
    J UOEH; 1988 Jun; 10(2):189-201. PubMed ID: 2900546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
    Primrose JN; Naik KS; Blackett RL; King RF; Holmfield JH; Lagopolous M; Johnston D
    Gut; 1990 Jul; 31(7):763-6. PubMed ID: 1973394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients. A controlled study.
    Parente F; Maconi G; Sangaletti O; Minguzzi M; Vago L; Bianchi Porro G
    Gut; 1995 Aug; 37(2):210-5. PubMed ID: 7557570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bombesin on gastrin and gastric acid secretion in patients with duodenal ulcer.
    Delle Fave G; Kohn A; De Magistris L; Annibale B; Bruzzone R; Sparvoli C; Severi C; Torsoli A
    Gut; 1983 Mar; 24(3):231-5. PubMed ID: 6826108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
    Colturi TJ; Unger RH; Feldman M
    J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori.
    Peterson WL; Barnett CC; Evans DJ; Feldman M; Carmody T; Richardson C; Walsh J; Graham DY
    Am J Gastroenterol; 1993 Dec; 88(12):2038-43. PubMed ID: 8249971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between basal serum gastrin concentrations and gastric acid secretion in peptic ulcer disease.
    Steen J; Herning M; Christiansen PM; Rehfeld JF
    Scand J Gastroenterol; 1980; 15(8):949-52. PubMed ID: 7233069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer.
    Banerjee S; El-Omar E; Mowat A; Ardill JE; Park RH; Watson W; Beattie AD; McColl KE
    Gastroenterology; 1996 Mar; 110(3):717-24. PubMed ID: 8608880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.